13F Portfolios

SurgoCap Partners LP — LPL FINL HLDGS INC LPLA: Quarterly 13F Position History

SurgoCap Partners LP has reported LPL FINL HLDGS INC (LPLA) on 10 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2023. As of Q1 2026, the position is sized at 1,020,839 shares ($307.1M market value, 10.25% of the equity book). Quarter-over-quarter share count change: + 25,839 (+2.6%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 10 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 1,020,839 +25,839 +2.6% $307.1M 10.25% $300.83
Q4 2025 995,000 +722 +0.1% $355.4M 9.84% $357.17
Q3 2025 994,278 +112,873 +12.8% $330.8M 9.39% $332.69
Q2 2025 881,405 25,037 -2.8% $330.5M 12.67% $374.97
Q1 2025 906,442 +197,172 +27.8% $296.5M 14.65% $327.14
Q4 2024 709,270 71,451 -9.2% $231.6M 13.41% $326.51
Q3 2024 780,721 +233,880 +42.8% $181.6M 9.69% $232.63
Q2 2024 546,841 +24,910 +4.8% $152.7M 8.93% $279.30
Q1 2024 521,931 54,688 -9.5% $137.9M 7.40% $264.20
Q4 2023 576,619 $131.3M 9.27% $227.62

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did SurgoCap Partners LP first disclose a LPLA position in 13F-HR filings?

SurgoCap Partners LP first reported LPL FINL HLDGS INC (LPLA) on its 13F-HR filing for the period ending 2023-12-31 (Q4 2023). The position has appeared on 10 reported quarters within Pactolio's tracked window.

What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in LPLA?

Between Q4 2025 and Q1 2026, SurgoCap Partners LP added 25,839 shares of LPLA (+2.6%), bringing the total reported position to 1,020,839 shares at a market value of $307.1M.

Does the implied price-per-share represent SurgoCap Partners LP's cost basis in LPLA?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.